CEO and Co-Founder of ImmunogenX, a biopharmaceutical company focused on therapeutic and diagnostic solutions for celiac disease. Dr. Syage has over 25 years of experience creating and leading the development of innovative technologies in the analytical instrumentation field. He is regarded as a leading expert in mass spectrometry and trace chemical detection. Previously he founded Syagen Technology, Inc. and led its growth culminating in the successful acquisition in 2011 by the $20B/yr French company Safran. Jack also sits on the Board of Directors of Advanced Telesensors, Flamentera AG, Analytical Detection, and Appellation Ventures. Jack has published over 130 papers, delivered over 80 invited talks, has over 30 U.S. patents issued or pending, and appears on the list of the Most Highly Cited Chemists. His honorary positions included Visiting Professor at UC Irvine, Visiting Professor at the Université de Paris-Sud, Editorial Board member of the Journal of Physical Chemistry, and invitee to the Nobel Symposium in Chemistry. He received BA and PhD degrees from Hamilton College and Brown University, respectively, where he won several academic awards including Best Thesis. He was a postdoctoral fellow at Caltech under Nobel Laureate Ahmed Zewail.